Pharmacotherapy in Psychiatric Disorders of Children: Current Evidence and Trends
1Department for Child and Adolescent Psychiatry and Psychotherapy, Medical School Brandenburg, Neuruppin.
Insights
Psychiatric medication for children shows strong evidence for ADHD but limited data for other disorders. Treatment decisions should prioritize symptom severity and functional impairment, with careful monitoring for adverse events.
Area of Science:
- Child and adolescent psychiatry
- Psychopharmacology
- Pediatric mental health
Background:
- Pharmacotherapeutic interventions are available for many pediatric psychiatric disorders, but evidence varies significantly.
- While ADHD has a robust evidence base for medication, data on efficacy and safety for disruptive behavior, anxiety, depression, and autism are scarcer.
- Off-label medication use in children is common, often due to a lack of specific market authorization studies.
Purpose of the Study:
- To provide an overview of current psychopharmacological interventions in child and adolescent psychiatry.
- To highlight the varying levels of evidence for different pediatric psychiatric conditions.
- To emphasize the importance of integrating pharmacotherapy within broader treatment plans.
Main Methods:
- Selective literature review of psychopharmacological interventions in child and adolescent psychiatry.
- Analysis of evidence regarding efficacy and safety for various pediatric mental health disorders.
- Examination of factors influencing medication decisions and guidelines.
Main Results:
- Evidence for psychopharmacological efficacy and safety is strongest for Attention-Deficit/Hyperactivity Disorder (ADHD).
- For other common disorders like disruptive behavior, anxiety, depression, and autism, evidence is less robust, with some studies indicating lower efficacy or less favorable benefit-risk profiles.
- Guidelines recommend pharmacotherapy be integrated with psychosocial interventions, with decisions based on symptom severity, chronicity, and functional impairment.
Conclusions:
- Psychopharmacotherapy in children requires careful consideration of evidence, symptom severity, and functional impairment.
- Adverse events necessitate close monitoring, and treatment should be managed by experienced mental health professionals.
- The integration of medication with psychosocial therapies is crucial for optimal outcomes in pediatric mental health care.
Abstract:
Pharmacotherapeutic interventions are available for most psychiatric disorders in children. Evidence for these interventions varies, depending on the targeted disorders. For attention-deficit/hyperactivity disorder, a sound database on efficacy and safety of medication exists. For other common disorders or psychopathological phenomena like disruptive behavior, anxiety disorders, depressive disorders, or autism, data on efficacy and safety are much scarcer. This selective review aims to provide an overview about current psychopharmacological interventions in child and adolescent psychiatry. The literature indicates either a lower efficacy than other interventions or less beneficial effects compared to possible adverse events in these cases. Most guidelines recommend psychopharmacotherapy in children to be embedded in a psychosocial or therapeutic intervention plan. Decision for medication depends on the severity of symptoms, chronicity, and, most important, impairment of the child in academic performance, family relationships, and everyday life. The high rates of off-label use in the age group of children are often due to a lack of market authorization studies less indicative of low efficacy. As adverse events need to be monitored closely, pharmacotherapy should mainly be restricted to experienced mental health care providers.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
01:28Drug Therapy
Antianxiety Medications
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:28Psychosis and Antipsychotic Drugs: Overview